Franklin M. Berger - 11 Nov 2022 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Franklin M. Berger
Issuer symbol
AVIR
Transactions as of
11 Nov 2022
Net transactions value
-$214,685
Form type
4
Filing time
15 Nov 2022, 19:00:11 UTC
Previous filing
14 Nov 2022
Next filing
23 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Sale $131,333 -25,500 -3.1% $5.15 794,519 11 Nov 2022 Direct F1, F2
transaction AVIR Common Stock Sale $83,352 -16,166 -2% $5.16 778,353 14 Nov 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1200 to $5.1947, inclusive.
F2 The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1000 to $5.2242, inclusive.